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In the United States, surgical procedures account for up to 450,000
pediatric admissions each year,1,2 with antibiotic prophylaxis
administered for>50% of surgeries.3–5 National guidelines provide
procedure-specific recommendations for antimicrobial prophy-
laxis, including drug and dosing, in an effort to reduce surgical site
infections.5 The 2017 Centers for Disease Control and Prevention
(CDC) guideline recommends only a single dose of perioperative
prophylaxis for clean and clean-contaminated cases.6
Despite these guidelines, inappropriate surgical prophylaxis use
continues to be common. In a pediatric study of surgical antibiotic
prophylaxis in 348,119 procedures, 35.4% of antibiotic prophylaxes
were considered inappropriate, with interhospital variability ranging
from 15.6% and 52.7%.3 In another study, Voit et al7 found that 28%
of surgical procedures had excess duration of antibiotic prophylaxis
prior to the new recommendation eliminating postoperative doses
in low-risk surgeries. In this multisite study, we aimed to determine




A point-prevalence survey (PPS) was conducted in 32 children’s
hospitals to document antimicrobial prescribing among hospitalized
patients. Data were collected during 6 quarterly cycles from
September 2016 to December 2017. Patients<18 years of age with
an active antimicrobial order at 8:00 AM on the day of the PPS
were eligible for inclusion. This methodology has been used in
similar studies.8,9 A chart review of the electronic medical record
was performed, and patient data (eg, age, sex, medical service
type, and underlying chronic conditions) and antimicrobial
characteristics (eg, name, route, indication, appropriateness) were
recorded in a Research Electronic Data Capture (REDCap) online
database. Additionally, for antibiotics, data were collected regard-
ing when or if the antimicrobial stewardship program (ASP) would
have routinely reviewed this antibiotic. For this post-hoc analysis,
we selected those patients who were receiving an antibiotic with an
EHR-documented indication for surgical prophylaxis.
Study outcome
The primary outcome was whether the antibiotic was inappropriate
or not, whichwas recorded on the day of the PPS. The determination
of inappropriate antibiotic administration was completed by the
physician(s) and/or clinical pharmacist(s) involved with the institu-
tion’s ASP. Several factors were considered when assigning appro-
priateness, including drug, route, and indication. If the antibiotic
was recorded as inappropriate, the reviewer indicated the primary
reason for inappropriateness from a prespecified list (ie, pathogen–
drug mismatch, surgical prophylaxis duration >24 hours, unnec-
essary duplicate therapies, intravenous medication that could be
administered orally, or other with free text response). A standard
operations manual that provided clear definitions of inappropri-
ateness was given to each participating institution.
Data analysis
The frequency of inappropriate surgical prophylaxis was calcu-
lated, stratified by surgical specialty (otolaryngology, orthopedic,
cardiovascular, neurosurgery, urology, cosmetic or reconstructive,
general surgery, other) and whether the ASP would routinely
review the antibiotic. Additionally, we evaluated the variability
in inappropriate surgical prophylaxis across the participating insti-
tutions. Analyses were completed using SAS version 9.4 software
(SAS Institute, Cary, NC). Institutional review board approval
was obtained for all sites.
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Results
Overall, 32 hospitals participated in at least 1 of 6 PPSs. Clinical
characteristics from 13,051 patients who were actively receiving
antimicrobial treatment were recorded during the study period.
Of these, 1,324 patients (1,477 orders) were receiving antibiotics
for surgical prophylaxis. The most commonly prescribed surgical
prophylaxis antibiotic was cefazolin (n = 788, 53.4%) followed by
clindamycin (n = 85, 5.8%), vancomycin (n = 85, 5.8%), cefoxitin
(n = 69, 4.7%), and piperacillin/tazobactam (n = 54, 3.7%).
Overall, 485 surgical prophylaxis antibiotics (33.0%) were
categorized as inappropriate. The most common reason was due
to prophylaxis of>24 hours (n= 387, 79.8%). Other inappropriate
reasons for surgical prophylaxis included prophylaxis not indi-
cated (n = 32, 6.6%) and antibiotic too broad (n = 29, 6.0%).
The frequency of inappropriate surgical prophylaxis was higher
among otolaryngologic surgery patients (62.7%; 95% confidence
interval [CI], 52.6–72.1) cosmetic or reconstructive surgery patients
(40.7%; 95% CI, 30.0–52.2), and neurosurgery patients (40.3%;
95% CI, 34.2–46.6) compared with orthopedic surgery patients
(15.5%; 95% CI, 11.1–20.7) and cardiovascular surgery patients
(24.5%; 95% CI, 20.1–29.3). Of the 485 surgical prophylaxis pre-
scriptions reviewed that were determined to be inappropriate, most
(n = 258, 53.2%) would not have been routinely reviewed by the
ASP. Inappropriate surgical prophylaxis varied significantly
across the 32 hospitals, from 0.0% to 62.8% (Fig. 1).
Discussion
This study demonstrates the continued and consistent inappropri-
ate use of surgical antibiotic prophylaxis in children. Similar to
previous studies,3,4,10 33% of surgical antibiotic prophylaxis was
considered inappropriate. The most common reason for inappro-
priate use was prolonged duration of prophylaxis for>24 hours. In
light of the new CDC guideline recommending no doses for low-
risk procedures, our inappropriate rate is likely an underestimate.
In addition, institutional-level inappropriateness in this study
varied from 0 to 63%, which agrees with prior research.3
This study has several limitations. First, the PPS methodology
provides a 1-day glimpse of antimicrobial use within a hospital
which may not be entirely comprehensive of all surgeries, includ-
ing procedures where prophylaxis was not given. However, the
prevalence of inappropriate use from our study shows similarity
with prior research. Lastly, categorizing an antibiotic as inappro-
priate or not was a perceived determination by ASP teammembers
within each institution, which may have introduced some differ-
ential classification. However, an operations manual was used to
help standardize the definition of inappropriateness. Moreover,
only a trained ASP physician and/or clinical pharmacist was
permitted to make the determination.
In conclusion, a significant portion of surgical antibiotic
prophylaxis is inappropriate. This study specifically highlights
the prolonged durations of prophylaxis being provided. Future
studies are needed to better estimate the overall rate of inappropriate
surgical prophylaxis, the factors that drive prolonged surgical pro-
phylaxis, and the best interventions to improve the use of surgical
antibiotic prophylaxis.
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Fig. 1. Inappropriate surgical prophylaxis by study hospital.
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Pharyngitis is a common reason for outpatient antibiotic prescrib-
ing in the United States.1,2 With few exceptions, antibiotics should
be prescribed for pharyngitis only after confirmation of group
A Streptococcus (GAS) by laboratory testing.3 Because rapid
antigen-detection tests (RADTs) have a specificity >95% but a
sensitivity that is often<90% compared to throat cultures, national
guidelines recommend performing cultures when RADTs are
negative in children, but not in adults.3,4 Inappropriate antibiotic
prescribing for pharyngitis occurs when antibiotics are prescribed
without testing or when antibiotics other than narrow-spectrum
penicillins are chosen for nonallergic patients.3,5 Because the
prevalence of GAS among cases of pharyngitis is estimated to be
20%–30% in children and 5%–15% in adults, prescription rates
higher than these thresholds suggest overuse.1,3 Appropriate
laboratory testing for pharyngitis in patients who are prescribed
antibiotics is a Healthcare Effectiveness Data and Information
Set (HEDIS) performance measure in children, and it will expand
in 2020 to include adults.5 Our objectives in this study were to
describe use of laboratory testing and antibiotic prescribing for
GAS in the United States.
Methods
We performed a cross-sectional analysis of data from the
2014–2016 National Ambulatory Medical Care surveys, annual
surveys of visits to office-based physicians conducted by the
National Center for Health Statistics.6 Data included tests per-
formed (test results not available), diagnoses using International
Classification of Diseases, Ninth and Tenth Revisions, Clinical
Modification (ICD-9-CM and ICD-10-CM) codes, and medica-
tions. National estimates were generated by applying visit weights
to the multistage probability sample.
We included visits by children (aged 3–17 years) and
adults (aged ≥18 years) with acute pharyngitis, streptococcal sore
throat, or acute tonsillitis (ICD-9-CM codes 462–463, 034 and
ICD-10-CM codes J02–J03). Laboratory tests included RADTs
and throat cultures. In analyses of antibiotic prescribing, we
excluded visits with additional diagnoses potentially warranting
antibiotics (eg, urinary tract infection or pneumonia).1
Recommended antibiotics included narrow-spectrum penicillins.3
Antibiotics were identified usingMultum Lexicon therapeutic class
and generic drug codes.
The main outcomes were (1) the proportions of visits for
pharyngitis in which laboratory tests were performed (overall
and among visits with antibiotics prescribed); (2) the proportion
of visits in which an antibiotic prescription was not associated with
performance of a laboratory test; and (3) the proportion of antibi-
otic prescriptions that were in the recommended category.
Estimates and 95% confidence intervals (CIs) accounted for the
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